Coagulation Disorders

  • Dana-Farber/Brigham and Women's Cancer Care

    Coagulation disorders refer to blood diseases in which the blood does not clot properly, which can lead to an increased risk of bleeding (hemorrhage) or obstructive clotting (thrombosis).  Learn about coagulation disorders and find information on how we support and care for people with these disorders before, during, and after treatment.

Treatment 

The Adult Hematology Treatment Center at Dana-Farber/Brigham and Women’s Cancer Center is one of the largest and most respected treatment centers in the world for patients with disorders of the blood or bone marrow.

Because hematological disorders take many different forms, your care team includes experts with specialized knowledge in treating your condition.

Our physicians, radiologists, nurse practitioners, and other care providers work closely together to develop a treatment approach tailored to the unique characteristics of your disease and to accommodating your individual needs.

The Center also conducts a wide range of clinical research. in which potential new therapies are tested and evaluated. Clinical trials give patients access to the latest, most advanced treatments available.

The Center provides treatment for patients with a wide array of conditions, including:

Anemia and other red blood cell disorders, including iron deficiency anemia, anemia of chronic disease, vitamin B12 deficiency, sickle cell anemia, and thalassemia.

Disorders of coagulation and thrombosis such as hemophilia, von Willibrand’s disease, factor V Leiden, and antiphospholipid syndrome.

White blood cell disorders,including neutropeniaand leukocytosis.

Platelet disorders, such as thrombocytopenia (ITP and TTP) and thrombocytosis.

Myeloproliferative disorders, which include polycythemia vera, thrombocythemia, chronic myelogenous leukemia, and primary myelofibrosis.

Bone marrow failure disorders, such as aplastic anemia, myelodysplasia, and paroxysmal nocturnal hemoglobinuria.

Iron metabolism disorders, including hemochromatosis and porphyria.

Plasma cells and antibody production disorders, which include benign monoclonal gammopathy, cryoglobulinemia, and amyloidosis.

The Center also helps patients manage anticoagulant medications, such as warfarin, low molecular weight heparin, and anti-platelet agents.

Learn more about patient care at the Hematology Treatment Center 

Contact us 

Referring physicians: 617-732-6089
New patient inquiries: 617-732-6089
All other inquiries: 617-732-5190
Fax: 617-732-5706

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Make an Appointment

    • For adults:
      877-442-3324 (877-442-DFCI)
    • For children:
      888-733-4662 (888-PEDI-ONC)
    • Or complete the online form.
  • Highest ranked in New England